Browsing by Author "Elesaily, Khaled"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Molecular Detection of Genetic Susceptibility to Bladder Cancer in Egyptian Patients
    (Asia Pacific Organization for Cancer Prevention (APOCP), 2022-01) Mamdouh, Samah; Khorshed, Fatma; Hammad, Gehan; Elesaily, Khaled; Safwat, Gehan; Hammam, Olfat; Aboushousha, Tarek
    Objective: Genome-wide association studies (GWAS) have identified a number of genetic variants associated with the susceptibility of bladder cancer (BC) in European and Chinese populations. Here, we assessed the association of two of these variants, rs9642880 and rs710521 in an Egyptian patients and also examined the expression of c-Myc.The basis was due to the absence of studies on Egyptian patients to determine the association between rs9642880& rs710521 and bladder cancer risk, particularly due to the known role of the variant (rs9642880) in the Progression and development of bladder cancer. Methods: Urine samples were collected from onehundred and fiftybladder cancer patients under particular standards and fifty healthy controls. Genomic DNA was extracted, rs9642880 G>T and rs710521 A>G polymorphisms were amplified, assessed via restriction fragment length polymorphism(RFLP) and sequenced. Urine retrieved results were compared to the histopathological diagnosis of tissue biopsies and to the results of C-Myc immunohistochemistry. Data were statistically analyzed using Microsoft Excel 2016, association between significant genotypes of the two studied variables and bladder cancer risk was performed. Results: We found that the TT genotype of rs9642880 G>T was strongly associated with the risk of bladder cancer, andfor rs710521 A>G, AG genotype was also identified to has an association with bladder cancer risk.All 150 tumor sections showed positive immunoreactivity for c-Myc in the nucleus and the cytoplasm. Conclusion: Identifying the association to risk of bladder cancer using genetic analysis will help in the early detection of the disease.
  • Thumbnail Image
    Item
    TP53 Mutation for Prediction of Tumor Recurrence and Metastasis in Bladder Cancer Patients
    (Springer nature, 2022-03) Mamdouh, Samah; Khorshed, Fatma; Aboushousha, Tarek; Safwat, Gehan; Elesaily, Khaled
    Background: Bladder cancer (BC) is one of the most commonly diagnosed malignancies worldwide. Its complex etiopathogenesis is dependent on numerous risk factors that can be divided into three distinct categories: genetic and molecular abnormalities, chemical or environmental exposure and previous genitourinary disorders and family history of different malignancies. This study highlights the genetic and molecular abnormalities that considered to be part of bladder carcinogenesis such as genetic mutations of TP53. To date, cystoscopy remains the gold standard for diagnosis, butit is invasive and uncomfortable. Hence, many efforts are focusing on the development of accuratenon-invasive diagnostic tests for BC, consequently, this study aims to develop a new non-invasive and reliable test to accurately detect TP53 mutations in urine sediments of Egyptian BC patients and to evaluate the influence of their genetic status on tumor metastasis and recurrence as they are the main problems during the disease. Methods: A total of 150 BC patients and 50 healthy volunteers as controls were enrolled in this study, urine samples were obtained from all participants. DNA was extracted and TP53 mutations were examinedin exons (2+3), 4 and 5 by polymerase chain reaction (PCR). All PCR products were subjected to bidirectional sequencing. Results: Fifty four (36.0%) patients of 150 were mutated in exon (2+3) with statistically higher significant in patients when compared to controls (P = 0.001),while 96 patients(64.0%) in Exon 4, and 111 patients(74.0%) in Exon 5 with the same (P = 0.001).Moreover, a significant association was observed between TP53 status with tumor stage and grade, being alterations more common in high-stage and high-grade tumors. Conclusion: We conclude that TP53genetic mutations are independent prognostic factors for tumor metastasis and recurrence and the genetic alternation of TP53 could be used for prediction of bladder tumorigenesis.